Needs to be entrepreneurial spirited to begin with.
The kicker is that coming in with the appropriate experience and skills, means you had to work at medium to large size company and brought products to market. If you've done that - coming into a company like Peregrine with a first-time-to-market product can feel a little shaky.
At the same time - if you've done that, you have quite a breadth of skills that go way beyond building a commercial business. You understand disease biology, potential therapeutic and market value, clinical data, and more. Seeing some of the evidence, and I mean public and shareable only, can make quite the impact on one's interest in taking on risk.
Coming into a small company presents a high-risk scenario that should come with high-reward. One can expect a sign-on bonus inclusive of (cheap) stock options that can appreciate quite well once the product is in-line to go with that risk, as well as a sales-incentive-driven compensation program that can pay quite handsomely for an oncology product, if successful.
If one's entrepreneurial, and can handle the risk - it's a great opportunity.
It's not for everyone - but neither is coming in to a small company to build a commercialization engine from scratch.
I would take it :)
Best,
MH
Market Data 
Markets 
AI
